The revenue in the 'Vitamins & Minerals' segment of the otc pharmaceuticals market in the United States was forecast to continuously increase between 2024 and 2029 by in total 1.2 billion U.S. dollars (+26.2 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 5.73 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Vitamins & Minerals' segment of the otc pharmaceuticals market was continuously increasing over the past years.
Data provided by Statista Market Insights are estimates.
Definition: The Vitamins and Minerals market comprises over-the-counter natural and synthetic food supplements like multivitamin preparations, minerals, vitamins, tonics and cod liver oil. Vitamins and minerals include preparations in the form of capsules, dragees, pills, granulate, ampoules, solutions, powders, syrups for oral use. Not included are prescription medicines, preparations that are not explicit food supplement drugs (e.g. muscle-building preparations) or primarily serve cosmetic purposes. Among the top-selling vitamin and mineral products are Vitasprint, Orthomol, magnesium granulate, Curazink, Centrum. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information: The market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included. For more information on the data displayed, use the info button next to the boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista Market Insights. (December 2, 2024). Revenue in the vitamins & minerals segment of the OTC pharmaceuticals market United States from 2018 to 2029 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 24, 2024, from https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states
Statista Market Insights. "Revenue in the vitamins & minerals segment of the OTC pharmaceuticals market United States from 2018 to 2029 (in billion U.S. dollars)." Chart. December 2, 2024. Statista. Accessed December 24, 2024. https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states
Statista Market Insights. (2024). Revenue in the vitamins & minerals segment of the OTC pharmaceuticals market United States from 2018 to 2029 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 24, 2024. https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states
Statista Market Insights. "Revenue in The Vitamins & Minerals Segment of The Otc Pharmaceuticals Market United States from 2018 to 2029 (in Billion U.S. Dollars)." Statista, Statista Inc., 2 Dec 2024, https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states
Statista Market Insights, Revenue in the vitamins & minerals segment of the OTC pharmaceuticals market United States from 2018 to 2029 (in billion U.S. dollars) Statista, https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states (last visited December 24, 2024)
Revenue in the vitamins & minerals segment of the OTC pharmaceuticals market United States from 2018 to 2029 (in billion U.S. dollars) [Graph], Statista Market Insights, December 2, 2024. [Online]. Available: https://www.statista.com/forecasts/1435302/revenue-vitamins-minerals-otc-pharmaceuticals-market-united-states